HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flavia Pricci Selected Research

Flavia Pricci Research Topics

Disease

3Inflammation (Inflammations)
01/2019 - 09/2005
3Diabetic Nephropathies (Diabetic Nephropathy)
06/2006 - 08/2003
2Diabetic Retinopathy (Retinopathy, Diabetic)
08/2018 - 01/2015
2Diabetes Complications
01/2017 - 08/2003
2Atherosclerosis
07/2009 - 06/2009
1Hypopituitarism (Sheehan's Syndrome)
03/2022
1Acute Kidney Injury (Acute Renal Failure)
10/2020
1Disease Susceptibility (Diathesis)
10/2020
1COVID-19
10/2020
1Gliosis
01/2019
1Hypertensive Retinopathy
01/2019
1Hypertension (High Blood Pressure)
01/2019
1Glaucoma
08/2018
1Ischemia
08/2018
1Disease Progression
01/2017
1Macular Edema
01/2016
1Non-alcoholic Fatty Liver Disease
05/2011
1Insulin Resistance
05/2011
1Fibrosis (Cirrhosis)
05/2011
1Proteinuria
09/2005
1Albuminuria
09/2005
1Sclerosis
09/2005
1Hyperglycemia
03/2005
1Hypersensitivity (Allergy)
08/2003
1Diabetic Angiopathies (Diabetic Angiopathy)
08/2003

Drug/Important Bio-Agent (IBA)

4Galectin 3 (LGALS3)IBA
05/2011 - 08/2003
3LipidsIBA
05/2011 - 06/2009
2Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2005
2Retinaldehyde (Retinal)IBA
01/2019 - 01/2015
2Messenger RNA (mRNA)IBA
09/2005 - 08/2003
1Biological ProductsIBA
10/2020
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2019
1Glial Fibrillary Acidic ProteinIBA
01/2019
1Ophthalmic Solutions (Eye Drops)IBA
01/2019
1Glutamate Receptors (Glutamate Receptor)IBA
08/2018
1Pharmaceutical PreparationsIBA
01/2017
1Advanced Glycation End ProductsIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Therapeutic UsesIBA
01/2016
1Fatty Acids (Saturated Fatty Acids)IBA
05/2011
1Lipoproteins (Lipoprotein)IBA
06/2009
1Glucose (Dextrose)FDA LinkGeneric
06/2006
1Receptor for Advanced Glycation End ProductsIBA
09/2005
1Streptozocin (Streptozotocin)FDA Link
04/2005
1Adenosine Triphosphate (ATP)IBA
03/2005
1Cell Surface ReceptorsIBA
08/2003

Therapy/Procedure

1Hypophysectomy
03/2022
1Investigational Therapies (Experimental Therapy)
10/2020
1Topical Administration
01/2019